Watanabe Todd sold ARQT
August 3, 2026 · Form 4 insider transaction
Watanabe Todd sold 4,375 shares of Arcutis Biotherapeutics, Inc. at $26.12 per share, a transaction worth $114.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.; The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $25.72 to $26.69, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.; Includes 823 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2026.